Reform FDA advisory committees and put rare disease patients first

The Food and Drug Administration (FDA) is failing patients with life-threatening rare diseases. As a biochemist and public health expert, I have witnessed officials turning a blind eye to the needs, concerns, and voices of families caring for the nearly 30 million Americans — half of them children — with debilitating and terminal rare conditions. […]